# Centenara Labs AG: Research, Schlieren, Switzerland

> Centenara Labs AG: Centenara Labs AG is a clinical-stage biotechnology company based in Schlieren, Zurich, Switzerland, with operations in Barcelona, Spain.

Source: https://millionrounds.com/startup/centenara-labs-ag (Millionrounds; every figure on the page links to its filing or article)

Switzerland · [Research startup](https://millionrounds.com/companies)

# Centenara Labs AG

Centenara Labs AG is a clinical-stage biotechnology company based in Schlieren, Zurich, Switzerland, with operations in Barcelona, Spain.

Funding reported Last round: Series B

Research Schlieren, Switzerland

Company summary

- **Founded:** 2019 7 years old
- **Team:** 7 1 to 10 people
- **Funding reported:** 174.1M as listed, currency not stated
- **Last round:** Series B Sept 2023

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Centenara Labs AG has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Centenara Labs AG

Centenara Labs AG is a clinical-stage biotechnology company based in Schlieren, Zurich, Switzerland, with operations in Barcelona, Spain.

Founded in 2019, the company focuses on developing therapies that target the hallmarks of aging, aiming to promote healthy aging and address age-related diseases such as cancer, fibrosis, and neurodegenerative disorders. In August 2024, the company rebranded from Rejuveron Life Sciences AG to Centenara Labs AG to reflect its evolved strategic focus. Operating under a "hub and spoke" model, Centenara Labs provides funding, mentorship, and operational support to scientific entrepreneurs and portfolio companies. The company is advancing a clinical-stage pipeline that includes therapies for retinitis pigmentosa and age-related sarcopenia, along with pre-clinical programs targeting cellular senescence and neurodegenerative diseases. Centenara Labs is dedicated to translating scientific research into innovative medicines that improve the quality of life for older adults and reduce the strain on global healthcare systems.

## What company datasets say Centenara Labs AG raised

Funding, as reported

Reported in all **174.1M** in the source's currency

Last round **Series B**

Last round size **75M**

Last round date **Sept 2023**

Investors listed **3**

## Founders and team

From Centenara Labs AG's own website: 1 founder, 3 on the team.

**Christian Angermayer** Co-founder and Chair of the Board

- **Etienne Binant** Chief Executive Officer
- **Lisa Balsiger** Operations Manager
- **Shannon Klinger** Independent Board Member

Advisers *Matt Kaeberlein PhD* *Prof. Brian Kennedy PhD*

## On 4 portfolio pages

Investors who name them

- [Korify Capital](https://millionrounds.com/fund/korify-capital)
- [McKenny-McFarlane Capital](https://millionrounds.com/fund/mckenny-mcfarlane-capital)
- [Manta Capital Advisors](https://millionrounds.com/fund/manta-capital-advisors)
- [p53](https://millionrounds.com/fund/p53)

Each firm lists Centenara Labs AG on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## The company, in detail

What they build

Known for

health care senescent cells senescence targeting biotechnology research longevity science hallmarks of aging therapies healthspan extension hospital & health care clinical stage therapies medical telomere repair telomere restoration health biotechnology portfolio companies aging biology

Built with from their website

Trend Micro Email Security Google Tag Manager punycode WordPress.org Tailwind CSS Font Awesome Cloudflare DNS CloudFlare Viewport Meta Visual Composer

+8 more

CookieYes Google Analytics HTTP/3 Cloudflare WAF Google Analytics 4 Wordpress Microsoft Exchange Online Apple Business Manager

- **Sector:** Research
- **Industry code:** NAICS 541714, SIC 2834, 8731
- **Region:** Zurich

## Research in Switzerland

Startups like it

- [**Nouscom** Basel · founded 2015 *Raised*](https://millionrounds.com/company/nouscom)
- [**Hedera Dx** Epalinges · founded 2021 *Raised*](https://millionrounds.com/company/hedera-dx)
- [**Bio Protocol** Zug *Raised*](https://millionrounds.com/company/bio-protocol)
- [**InVirtuoLabs** Lugano · founded 2024 *Raised*](https://millionrounds.com/company/invirtuolabs)
- [**NEMIS Technologies** Waedenswil · founded 2018 *Raised*](https://millionrounds.com/company/nemis-technologies)
- [**Windward Bio** Basel](https://millionrounds.com/startup/windward-bio)
- [**Bright Peak Therapeutics** Basel · founded 2017](https://millionrounds.com/startup/bright-peak-therapeutics)
- [**Numab Therapeutics AG** Horgen · founded 2011](https://millionrounds.com/startup/numab-therapeutics-ag)

## Is this your company?

Add your raise, your deck and your story, and put Centenara Labs AG in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)